Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.282 SEK
−27.04 M SEK
0.00 SEK
135.57 M
About BIOSERGEN AB
Sector
Industry
CEO
Tine Kold Olesen
Website
Headquarters
Solna
Founded
2021
ISIN
SE0016013460
FIGI
BBG0113QWRZ2
Biosergen AB operates as a biopharmaceutical company. It focuses on the clinical development of the antifungal product BSG005, is a potentially disruptive antifungal drug used for the treatment of life threatening invasive fungal disease. The company is headquartered in Solna, Sweden.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of BIOSGN is 0.572 SEK — it has increased by 14.40% in the past 24 hours. Watch BIOSERGEN AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange BIOSERGEN AB stocks are traded under the ticker BIOSGN.
BIOSGN stock has fallen by −6.54% compared to the previous week, the month change is a −4.67% fall, over the last year BIOSERGEN AB has showed a −41.03% decrease.
We've gathered analysts' opinions on BIOSERGEN AB future price: according to them, BIOSGN price has a max estimate of 1.30 SEK and a min estimate of 1.30 SEK. Watch BIOSGN chart and read a more detailed BIOSERGEN AB stock forecast: see what analysts think of BIOSERGEN AB and suggest that you do with its stocks.
BIOSGN reached its all-time high on Aug 10, 2021 with the price of 23.000 SEK, and its all-time low was 0.270 SEK and was reached on May 13, 2024. View more price dynamics on BIOSGN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
BIOSGN stock is 14.40% volatile and has beta coefficient of −1.05. Track BIOSERGEN AB stock price on the chart and check out the list of the most volatile stocks — is BIOSERGEN AB there?
Today BIOSERGEN AB has the market capitalization of 134.32 M, it has increased by 33.86% over the last week.
Yes, you can track BIOSERGEN AB financials in yearly and quarterly reports right on TradingView.
BIOSERGEN AB is going to release the next earnings report on Mar 31, 2025. Keep track of upcoming events with our Earnings Calendar.
BIOSERGEN AB revenue for the last quarter amounts to 0.00 SEK, matching the estimated figure, and no changes in revenue are expected for the next quarter.
BIOSGN net income for the last quarter is −4.33 M SEK, while the quarter before that showed −5.73 M SEK of net income which accounts for 24.34% change. Track more BIOSERGEN AB financial stats to get the full picture.
No, BIOSGN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 26, 2024, the company has 3.00 employees. See our rating of the largest employees — is BIOSERGEN AB on this list?
Like other stocks, BIOSGN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOSERGEN AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIOSERGEN AB technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIOSERGEN AB stock shows the sell signal. See more of BIOSERGEN AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.